TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ELDN

Eledon Pharmaceuticals Inc

Healthcare · Biotechnology

2.70$ -1.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Eledon Pharmaceuticals Inc (ELDN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 126 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ELDN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
96 126 81 120 115 177 161 145 130 169 147 126
63 56 48 87 82 144 128 111 96 136 114 93
3.7 4.6 5.7 26 6.8 21 8.5 5.7 3.7 23 6.2 6.8
60 51 43 84 78 140 125 108 93 133 111 89
– – – – – – 0.8 0.7 0.8 0.5 0.6 0.4
32 32 32 32 32 32 32 32 32 32 32 32
4.7 42 6.0 129 39 59 47 39 94 88 46 54
2.9 3.9 4.2 6.0 12 12 9.2 14 14 18 13 12
0.4 0.4 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.4 0.4 0.4
0.5 1.0 1.9 2.1 5.9 5.8 2.9 5.8 4.6 3.6 6.6 3.2
91 83 75 -8.5 76 118 115 106 35 81 100 72
-234 -243 -253 -388 -311 -356 -362 -373 -391 -401 -440 -472
30 24 30 42 55 60 77 77 77 75 112 114

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?